Ikarian Capital, LLC

SEC CIK: 0001778253
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

KRYS holding history

Krystal Biotech, Inc. in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KRYS overview All 13F holders of KRYS Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2025

Holdings of KRYS by Ikarian Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−14,814−100.0%	Sold out	Holders
Q4 2025	14,814	$3.65M	0.5%	−9,607−39.3%	Reduced	Holders
Q3 2025	24,421	$4.31M	1.0%	+24,421	New	Holders